Form 4: Medtronic Director Denise M. O'Leary Reports Acquisition of Shares

Director Denise M. O'Leary reports acquiring 2,165 Medtronic shares at $80.86 each, increasing her total holdings to 77,249 shares.

Summary

• On April 29, 2024, Denise M. O'Leary, a director of Medtronic plc, acquired 2,165 ordinary shares of Medtronic at a price of $80.86 per share.
• This acquisition was part of a restricted stock unit award that will vest on the one-year anniversary of the award date.
• Following this transaction, O'Leary's total beneficial ownership of Medtronic shares increased to 77,249, which includes 1,246 shares acquired through dividend reinvestment since her last report.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of a director's share acquisition, suggesting confidence but not necessarily a major event.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Director share acquisitions are common and closely monitored as they can reflect management's sentiment about the company's prospects. This transaction is a routine disclosure under Section 16 of the Securities Exchange Act.

Stakeholder Impact

• The acquisition could have a minor positive impact on shareholder sentiment.

Key Dates